These results strongly suggest that diabetes promotes IL-6 production in myeloid cells through increased PGE2-EP4 signaling, whereas PGE2-EP4 signaling acts to suppress TNF-α production in the setting of diabetes. The gene discussed is IL6; the disease is diabetes mellitus.